Jakavi 20mg Tablet (Ruxolitinib) – Global Exporter | Pratibha Pharma India
Looking for a trusted supplier of Jakavi 20mg Tablet? Pratibha Pharma, located in Nagpur, is a leading pharmaceutical exporter specializing in oncology and specialty medicines with fast, secure worldwide delivery.
🌍 Exporting to High-Demand Countries & Cities
We supply Jakavi 20mg Tablets across major global markets:
- United States – New York, Los Angeles, Houston, Chicago
- United Kingdom – London, Birmingham, Manchester
- Canada – Toronto, Vancouver
- Australia – Sydney, Melbourne
- United Arab Emirates – Dubai, Abu Dhabi
- Singapore
- South Africa – Johannesburg, Cape Town
💊 About Jakavi 20mg Tablet
Jakavi 20mg Tablet (Ruxolitinib) is a targeted therapy used in the treatment of:
- Myelofibrosis
- Polycythemia Vera
- Certain hematologic disorders
It works by inhibiting JAK1 and JAK2 enzymes, helping regulate abnormal blood cell production and reduce symptoms.
⭐ Key Benefits
✔ High-strength 20mg dosage for effective treatment
✔ Trusted oncology formulation
✔ Suitable for long-term therapy under medical supervision
✔ Export-quality packaging with safety assurance
🚚 Why Choose Pratibha Pharma?
- ✅ Reliable pharma exporter from India
- ✅ Competitive bulk pricing
- ✅ Fast international delivery (7–10 days)
- ✅ 100% genuine & quality-assured medicines
- ✅ Worldwide shipping with tracking support
📦 Bulk Orders & Global Supply
We export Jakavi 20mg Tablets in bulk to hospitals, pharmacies, and distributors with full export documentation and compliance support.
Jakavi 20mg exporter India, Ruxolitinib 20mg supplier, buy Jakavi online USA UK Canada, oncology medicine exporter worldwide, myelofibrosis treatment drug supplier, bulk cancer medicine exporter India, fast delivery pharma exporter, Pratibha Pharma Nagpur exporter
